Invention Grant
- Patent Title: E2F reporter melanoma cells
-
Application No.: US17011015Application Date: 2020-09-03
-
Publication No.: US11571483B2Publication Date: 2023-02-07
- Inventor: Andrew Aplin , Jessica Teh
- Applicant: THOMAS JEFFERSON UNIVERSITY
- Applicant Address: US PA Philadelphia
- Assignee: THOMAS JEFFERSON UNIVERSITY
- Current Assignee: THOMAS JEFFERSON UNIVERSITY
- Current Assignee Address: US PA Philadelphia
- Agency: Cozen O'Connor
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; A61K49/00 ; G01N33/50
Abstract:
A modified melanoma cell line capable of quantification of the effects of MEK inhibitors and CDK4/6 inhibitors in a quantitative, temporal and non-invasive manner both in vitro and in vivo.
Public/Granted literature
- US20210194941A1 E2F REPORTER MELANOMA CELLS Public/Granted day:2021-06-24
Information query
